title: Neuralgic amyotrophy due to rheumatoid arthritis or etanercept: causal association or coincidence?
authors.forename: Ajda
authors.initials: A
authors.lastname: Bal
authors.forename: Eda
authors.initials: E
authors.lastname: Gurcay
authors.forename: Ece
authors.initials: E
authors.lastname: Aydog
authors.forename: Ece
authors.initials: E
authors.lastname: Unlu
authors.forename: Ebru
authors.initials: E
authors.lastname: Umay
authors.forename: Aytul
authors.initials: A
authors.lastname: Cakci
mesh_terms: D018501:Antirheumatic Agents / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000150:complications* / Q000188:drug therapy; D020968:Brachial Plexus Neuritis / Q000209:etiology*; D000068800:Etanercept; D006801:Humans; D007074:Immunoglobulin G / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D018124:Receptors, Tumor Necrosis Factor
chemical_list: D018501:Antirheumatic Agents; D007074:Immunoglobulin G; D018124:Receptors, Tumor Necrosis Factor; D000068800:Etanercept